CTOs on the Move

Hillsdale Community Health Center

www.hchc.com

 
Hillsdale Community Health Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Hillsdale, MI. To find more information about Hillsdale Community Health Center, please visit www.hchc.com
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.hchc.com
  • 168 Hillsdale St
    Hillsdale, MI USA 49242-1243
  • Phone: 517.437.4451

Executives

Name Title Contact Details

Similar Companies

Happier Living

Happier Living is the premier national outpatient private practice that is expanding access to mental health as an in-network organization. We`re a strong community of highly qualified and passionate clinicians focused on long-standing therapeutic relationships with our clients.

Amkai

Amkai is a Armonk, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VNUS Medical Technologies

VNUS Medical Technologies, Inc. is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Community Health Center of Snohomish County

Community Health Center of Snohomish County (CHC) is a non-profit, Federally Qualified Community Health Center providing medical, dental, pharmacy, behavioral health, and additional ancillary services to nearly 70,000 individuals with 243,049 visits in 2021. For over 35 years, CHC has provided services to Snohomish County residents who face barriers to health care with the mission to provide our diverse community with access to high-quality, affordable primary health care. CHC operates seven medical primary care clinics, two medical walk-in clinics, six dental clinics, and five pharmacies, located in convenient locations in Arlington, Edmonds, Everett, and Lynnwood.

EyePoint Pharmaceuticals

EyePoint Pharmaceuticals is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company`s pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert`s proven intravitreal drug delivery platform has been safely administered to thousands of patients` eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.